We observed no significant difference in the rate of participants with detectable AIM+CD4+ T cells between the COVID-19-naive young and older adults according to stimulation index (89.8% versus 97.9%, respectively, p > 0.05) and similar frequency of AIM+CD4+ among CD4+ T cell in both groups (Figures 5A, B). This evidence concerns the gene CD4 and COVID-19.